Hematological, inflammatory, and novel biomarkers assessment as an eminent strategy for clinical management of COVID-19
Background: Different biomarkers have been suggested as novel biomarkers of coronavirus disease 2019 (COVID-19) theragnosis. With the aim of having a better clinical management of COVID-19, we decided to determine the relationship between hematological, inflammatory, and novel biomarkers with severe...
Main Authors: | Sanaz Rezaeian, Fatemeh Razmjooei, Masoome Pourmokhtari, Amir Abdoli, Mirza Ali Mofazzal Jahromi, Kambiz Bagheri |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023101046 |
Similar Items
-
CAR T Cell Therapy in Hematological Malignancies: Implications of the Tumor Microenvironment and Biomarkers on Efficacy and Toxicity
by: Jing Yuan Tan, et al.
Published: (2022-06-01) -
Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
by: Yu J, et al.
Published: (2023-07-01) -
A cross-sectional study on the role of hematological and inflammatory biomarkers as predictor of mortality at the time of admission among COVID-19 patients
by: Sanjay Kumar Totade, et al.
Published: (2023-03-01) -
Clinical trial-identified inflammatory biomarkers in breast and pancreatic cancers
by: Jing Peng, et al.
Published: (2023-04-01) -
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
by: Era L. Pogosova-Agadjanyan, et al.
Published: (2023-03-01)